3 results
The primary aim is to investigate the effect of neuromodulation (via UCon) on the symptoms of patients with PGAD. The hypothesis we want to test is whether neuromodulation of the DGN reduces the severity of symptoms of PGAD.
Primary Objective(s)Phase I (completed)The primary objective of the Phase I portion of the study is to determine the maximum tolerated dose (MTD) of the combination of melflufen and dexamethasone in patients with relapsed/refractory multiple myeloma…
Primary Objective: • Compare the diagnostic performance of the low dose abdominal CT scan to the normal dose abdominal CT scan in diagnosing causes of abdominal pain.Secondary Objectives:• Compare the diagnostic performance of diagnosing internal…